PE20011042A1 - Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan - Google Patents
Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecanInfo
- Publication number
- PE20011042A1 PE20011042A1 PE2001000027A PE2001000027A PE20011042A1 PE 20011042 A1 PE20011042 A1 PE 20011042A1 PE 2001000027 A PE2001000027 A PE 2001000027A PE 2001000027 A PE2001000027 A PE 2001000027A PE 20011042 A1 PE20011042 A1 PE 20011042A1
- Authority
- PE
- Peru
- Prior art keywords
- irinotecan
- glutamine
- late onset
- prevention
- day
- Prior art date
Links
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 title abstract 3
- 101100020619 Arabidopsis thaliana LATE gene Proteins 0.000 title abstract 2
- 206010012735 Diarrhoea Diseases 0.000 title abstract 2
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 title abstract 2
- 229960004768 irinotecan Drugs 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229910052711 selenium Inorganic materials 0.000 abstract 1
- 239000011669 selenium Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: a) DE 10gr A 150gr POR DIA DE GLUTAMINA; b) VITAMINAS TAL COMO A, C Y E; c) PROTEINAS; d) SELENIO . LA DOSIS DE GLUTAMINA ES DIVIDIDA EN 2 HASTA 12 DOSIS INDIVIDUALES ADMINISTRADAS PERIODICAMENTE DURANTE EL DIA. LA COMPOSICION ES ADMINISTRADA EL MISMO DIA O AL DIA SIGUIENTE DE LA ADMINISTRACION DE IRINOTECAN. LA COMPOSICION ES UTIL PARA PREVENIR O REDUCIR EL DESARROLLO DE DIARREA CON INICIO TARDIO INDUCIDA POR IRINOTECAN
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48496200A | 2000-01-18 | 2000-01-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20011042A1 true PE20011042A1 (es) | 2001-09-26 |
Family
ID=23926357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000027A PE20011042A1 (es) | 2000-01-18 | 2001-01-12 | Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU2001229478A1 (es) |
| CO (1) | CO5280204A1 (es) |
| PE (1) | PE20011042A1 (es) |
| WO (1) | WO2001052828A2 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2295429A1 (en) * | 2000-01-06 | 2001-07-06 | Michael Michael | Treatment or prevention of diarrhea |
| WO2004103371A1 (en) * | 2003-05-21 | 2004-12-02 | Pharmacia & Upjohn Company Llc | Use of cftr inhibitors for the treatment of chemotherapy-induced diarrhea |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5786344A (en) * | 1994-07-05 | 1998-07-28 | Arch Development Corporation | Camptothecin drug combinations and methods with reduced side effects |
| US5646159A (en) * | 1994-07-20 | 1997-07-08 | Research Triangle Institute | Water-soluble esters of camptothecin compounds |
-
2001
- 2001-01-12 WO PCT/US2001/001270 patent/WO2001052828A2/en not_active Ceased
- 2001-01-12 PE PE2001000027A patent/PE20011042A1/es not_active Application Discontinuation
- 2001-01-12 CO CO01002004A patent/CO5280204A1/es not_active Application Discontinuation
- 2001-01-12 AU AU2001229478A patent/AU2001229478A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001052828A3 (en) | 2002-04-18 |
| AU2001229478A1 (en) | 2001-07-31 |
| CO5280204A1 (es) | 2003-05-30 |
| WO2001052828A2 (en) | 2001-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0954314T3 (da) | Doseringsformer til bedring af mandlig erektionsdefekt | |
| ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
| EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
| BRPI0108977B8 (pt) | compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo | |
| BR0015188A (pt) | Composições farmacêuticas | |
| GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
| BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
| MY118164A (en) | Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia | |
| MX2007006212A (es) | Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular. | |
| BG106095A (bg) | Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици | |
| YU49026B (sh) | UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE | |
| DK0680326T3 (da) | Farmaceutisk formulering af nikotinafhængighed. | |
| BR0211198A (pt) | Composições farmacêuticas e seu uso | |
| ES2168241T1 (es) | Preparacion farmaceutica que contiene tolperisona para administrar por via oral. | |
| AP2003002763A0 (en) | Controlled release formulations for oral administration | |
| MY141012A (en) | Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser | |
| YU36401A (sh) | Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem | |
| PL360492A1 (en) | Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates | |
| DE69928806D1 (de) | (-)-pseudoephedrin als sympathomimetisches arzneimittel | |
| DE59914183D1 (de) | Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz | |
| BRPI0413374A (pt) | composições para liberação de base fraca por um perìodo estendido de tempo | |
| PE20011042A1 (es) | Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| AR014082A1 (es) | Concentrado oral de sertralina | |
| SE0000303D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |